NCT01831687View on ClinicalTrials.gov

Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Fasting
Interventions
DRUG

Etodolac Extended Release Tablets USP 600mg

Etodolac Extended Release Tablets USP 600mg once a day

DRUG

Etodolac Extended Release Tablets 600mg

Etodolac Extended Release Tablets 600mg once a day

Trial Locations (1)

380 015

Veeda Clinical Research Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY